Added to YB: 2025-02-04
Pitch date: 2025-02-03
NOVN.SW [bullish]
Novartis AG
+13%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
Market Cap
CHF 243.9B
Pitch Price
CHF 93.36
Price Target
N/A
Dividend
3.40%
EV/EBITDA
10.59
P/E
17.42
EV/Sales
4.73
Sector
Pharmaceuticals
Category
growth
Creams, Semis and Oil - Novartis AG
NOVN.SW: Q4 beat, core EBIT +29%. 2025 guidance: mid-high single-digit rev growth, double-digit earnings growth. Kisqali momentum in early-stage breast cancer. Strong drug portfolio offsetting generic competition. Trades at discount vs peers. Exciting 2025 pipeline in oncology & cardiovascular.
Read full article (1 min)